Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
Clinical trial NCT05629546 · RECRUITING
Trial details
- NCT number
- NCT05629546
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-06
- Primary completion
- 2029-02-28
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.